Norwich Research Park has signed Vengrove as its investment partner to deliver an 800,000 sq ft expansion of the campus.
The new investment partnership will enable the site to cater to the evolving needs of both current and prospective tenants across the agribiotech, food biotech, industrial biotech and medtech market sub-sectors.
The park hosts a community of more than 30,000 people, underpinned by six institutions: the Earlham Institute, the John Innes Centre, Quadram Institute Bioscience, the Sainsbury Laboratory, the University of East Anglia and the Norfolk and Norwich University Hospital.
Andrew McLean, partner and head of development at Vengrove, said: “We are looking forward to supporting science by providing facilities that will help the transition from bench to boardroom and playing our part to unlock positive economic and social impact for the regional economy and tackle the big global challenges.”
Roz Bird, chief executive of Anglia Innovation Partnership, the management company for Norwich Research Park, said: “[The partnership] will enable us to activate existing planning consent and supply new, flexible laboratory and office accommodation to meet market demand.
“With the park full of high-growth companies, the time is right to create new accommodation that will be needed to meet the demands of growing companies and help attract and retain businesses that want to benefit from being located at Norwich Research Park.”
Photo © Anglia Innovation Partnership
Send feedback to Evelina Grecenko
Follow Estates Gazette
